Black Rock Inc. Day One Biopharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,533,442 shares of DAWN stock, worth $62.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,533,442
Previous 5,031,435
9.9%
Holding current value
$62.7 Million
Previous $83.1 Million
24.84%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
84MCall Options Held
144KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$109 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$89 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$81.5 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$67.5 Million1.92% of portfolio
-
Franklin Resources Inc San Mateo, CA3.87MShares$53.6 Million0.02% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.02B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...